Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$10.58 USD
-0.07 (-0.66%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $10.57 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 9/5/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | -0.07 |
Last EPS Surprise | -333.33% |
ABR | 1.60 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.15 |
Next Year | NA |
EPS (TTM) | -0.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 39.50M | 35.20M | NA | NA |
# of Estimates | 1 | 1 | NA | NA |
High Estimate | 39.50M | 35.20M | NA | NA |
Low Estimate | 39.50M | 35.20M | NA | NA |
Year ago Sales | 37.73M | 25.40M | 139.91M | NA |
Year over Year Growth Est. | 4.69% | 38.58% | NA | NA |
Earnings Estimates
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | -0.08 | -0.15 | NA |
# of Estimates | 1 | 1 | 1 | NA |
Most Recent Consensus | -0.04 | -0.08 | -0.15 | NA |
High Estimate | -0.04 | -0.08 | -0.15 | NA |
Low Estimate | -0.04 | -0.08 | -0.15 | NA |
Year ago EPS | 0.00 | -0.12 | -0.35 | -0.15 |
Year over Year Growth Est. | NA | 33.33% | 57.14% | NA |
Agreement - Estimate Revisions
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | NA |
Up Last 30 Days | 0 | 0 | 0 | NA |
Up Last 60 Days | 0 | 1 | 0 | NA |
Down Last 7 Days | 0 | 0 | 0 | NA |
Down Last 30 Days | 0 | 0 | 0 | NA |
Down Last 60 Days | 1 | 0 | 1 | NA |
Magnitude - Consensus Estimate Trend
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Current | -0.04 | -0.08 | -0.15 | NA |
7 Days Ago | -0.04 | -0.08 | -0.15 | NA |
30 Days Ago | -0.04 | -0.08 | -0.15 | NA |
60 Days Ago | 0.00 | -0.12 | -0.11 | NA |
90 Days Ago | 0.00 | -0.12 | -0.11 | NA |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (7/2024) |
Next Qtr (10/2024) |
Current Year (4/2025) |
Next Year (4/2026) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.04 | -0.08 | -0.15 | NA |
Zacks Consensus Estimate | -0.04 | -0.08 | -0.15 | NA |
Earnings ESP | 0.00% | 0.00% | 0.00% | NA |
Surprise - Reported Earnings History
Quarter Ending (4/2024) |
Quarter Ending (1/2024) |
Quarter Ending (10/2023) |
Quarter Ending (7/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.07 | -0.08 | -0.12 | 0.00 | NA |
Estimate | 0.03 | -0.02 | -0.09 | -0.04 | NA |
Difference | -0.10 | -0.06 | -0.03 | 0.04 | -0.04 |
Surprise | -333.33% | -300.00% | -33.33% | 100.00% | -141.67% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more